Doublet vs triplet combination therapy for multiple myeloma
New initiatives in the treatment of myeloma
Overcoming the challenges of evolving standards of care in CLL: advice for community physicians
Highlights of ASH in CLL
John Gribben et al.
KEYNOTE-183 trial of pembrolizumab in multiple myeloma: trial design and rationale